Toxicity of sunitinib plus bevacizumab in renal cell carcinoma - Reply Journal Article

  

Authors:	Feldman, D. R.; Scappaticci, F. A.; Motzer, R. J.
Article Title:	Toxicity of sunitinib plus bevacizumab in renal cell carcinoma - Reply
Keywords:	vasculotropin; adult; aged; fatigue; case report; bevacizumab; placebo; sunitinib; hypertension; letter; phase 2 clinical trial; mucosa inflammation; thrombocytopenia; cohort analysis; kidney carcinoma; lactate dehydrogenase; hypothyroidism; hand foot syndrome; haptoglobin; thrombotic thrombocytopenic purpura; reticulocyte count; phase 1 clinical trial (topic)
Journal Title:	Journal of Clinical Oncology
Volume:	28
Issue:	17
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2010-06-01
Start Page:	e286
End Page:	e287
Language:	English
DOI:	10.1200/jco.2009.27.3037
PROVIDER:	scopus
PUBMED:	20439632
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-79951803626&partnerID=40&md5=b7c1385fe35151b4271a783fcd4ec4a8
Notes:	--- - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/4049